Bromodomain-Selective BETi as Pediatric Anticancer Agents
Originally recorded September 25, 2020
Anang Shelat, PhD
Director, Lead Discovery Informatics and Compound Management
Department of Chemical Biology & Therapeutics
St. Jude Children's Research Hospital
Philip M. Potter, PhD
Department of Chemical Biology & Therapeutics
St. Jude Children's Research Hospital
